MEDP logo

MEDP

Medpace Holdings Inc.

$428.03
+$11.99(+2.88%)
59
Overall
60
Value
41
Tech
76
Quality
Market Cap
$15.47B
Volume
729.19K
52W Range
$250.05 - $628.92
Target Price
$565.45

Company Overview

Mkt Cap$15.47BPrice$428.03
Volume729.19KChange+2.88%
P/E Ratio38.3Open$421.45
Revenue$2.1BPrev Close$416.04
Net Income$404.4M52W Range$250.05 - $628.92
Div YieldN/ATarget$565.45
Overall59Value60
Quality76Technical41

No chart data available

About Medpace Holdings Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Medpace Holdings (MEDP)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Adaptive Biotechnologies (ADPT – Research Report) ...

Christine Brown6 days ago
ABCD
1SymbolPriceChangeVol
2MEDP$428.03+2.9%729.19K
3
4
5
6

Get Medpace Holdings Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.